Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
STN: BL 125296
Proper Name: None
Trade Name: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Manufacturer: Barr Labs, Inc.
Indication:
- Indicated for active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type 7
Product Information
Supporting Documents
- October 15, 2019 Approval Letter - Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
- Approval History, Letters, Reviews and Related Documents - Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
- Supporting Documents older than three years - Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Related Information
- FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.